April 13, 2017 / 1:17 PM / 3 months ago

BRIEF-Celsion reports preclinical results of Thermodox for treatment of bladder cancer

1 Min Read

April 13 (Reuters) - Celsion Corp

* Celsion Corporation reports preclinical results of Thermodox® for the treatment of bladder cancer published in the international journal of hyperthermia

* Celsion Corp - study reinforces Thermodox's unique, proprietary mechanism of action

* Celsion Corp - "a successful optima study will provide means to expand thermodox's utility for patients with bladder cancer." Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below